FEB 13, 2020 5:04 AM PST

Protein that suppresses immune system linked to lupus

WRITTEN BY: Tara Fernandez

 

A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and the development of systemic lupus erythematosus, or SLE. This protein, human leukocyte antigen G (HLA-G), is expressed on fetal derived placental cells and is thought to play a role in immune tolerance during pregnancy.

HLA-G has been the subject of intense study in the last two decades. In particular, scientists have been interested in how HLA-G-mediated pathways affect rejection after organ transplantation, or how tumors suppress hijack these to evade immune detection. 

Now, the research team led by Francesco Puppo at the University of Genoa has identified that patients with SLE have significantly elevated levels of HLA-G. The protein was found on the membrane of peripheral blood mononuclear cells, a subset of white blood cells that includes T cells and monocytes. The significant difference in HLA-G levels between lupus patients and healthy controls points to the protein’s possible involvement in the onset or progression of this autoimmune disease.

SLE affects nearly every organ system from the skin, joints and central nervous system to the brain and kidneys. The disease is more prevalent in women than men and is thought to be a result of complex genetic, environmental and hormonal factors. Lupus is characterized by an exaggerated immune response to the body’s own cells and tissues, causing this widespread organ damage.

 

 

Based on their findings, the authors hypothesize that the increased production of HLA-G on the surface of immune cells could reflect an attempt to control the imbalanced immune responses occurring during the systemic autoimmune diseases.

Further clinical studies are due to establish whether HLA-G could be leveraged for diagnostic or therapeutic purposes.

 

Sources: Scleroderma News, Human Immunology.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
FEB 19, 2020
Immunology
FEB 19, 2020
Rainbow trout hold the key to unravelling immunological mysteries
What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from th ...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently in ...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
The Antibody Test to See if You've Already Had the Coronavirus
Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiol ...
APR 08, 2020
Immunology
APR 08, 2020
How the Skin Shields Against Zika Infection
Aedes mosquitoes are native of Africa but are commonly found in regions of the Americas, Asia, and the Pacific. These da ...
APR 15, 2020
Immunology
APR 15, 2020
Does COVID-19 Attack the Immune System like HIV?
Researchers from the US and China have found that COVID-19 can destroy T cells, a type of lymphocyte that plays a key ro ...
Loading Comments...